Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. has shown a positive outlook, with an increase in normalized funds from operations (NFFO) estimates for both 2025 and 2026, reflecting strong earnings performance and management's encouraging guidance. The 2025 normalized FFO estimate is projected to rise to $4.80 per share, which aligns with management's revised guidance, and indicates an expected growth of 5.3% year-over-year. Furthermore, the projected 2026 FFO estimate of $5.03 per share slightly exceeds consensus expectations, suggesting continued financial momentum.

Bears say

National Health Investors Inc. exhibits a negative outlook primarily due to the anticipated lower earnings growth over the coming years, influenced by challenges related to operator transitions and potential underperformance during rent resets, particularly regarding key tenants. Additionally, the risk of weaker deferred rent collections further compounds this outlook, as the company could be adversely affected if operators face difficulties, especially in light of possible future pandemic-related disruptions. This combination of operational challenges and revenue uncertainties leads to caution concerning the company’s financial stability and long-term growth prospects.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Jan 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.